According to a market report by Lucintel, the future of the global research antibodies market looks promising with opportunities in the immunohistochemistry, munofluorescence, western blotting, flow cytometry, immunoprecipitation, and elisa markets. The global research antibodies market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand of personalized medicine and the development of novel drugs and protein therapeutics due to the growth in multiple sclerosis and parkinson's disease incidences.
In this market, monoclonal antibodies and polyclonal antibodies are the
major segments of research antibodies market by type.
Lucintel forecasts that monoclonal antibodies will remain the larger
segment over the forecast period due to monoclonal antibodies uses in the
discovery and development of new treatments for various cancer types and rise
in the number of initiatives in cancer research that call for highly selective
antibodies.
Within this market, immunohistochemistry will remain the largest segment
due to its substantial applications in the detection of enzymes, antigens,
tumor suppressor genes, and tumor cell proliferation for cell-based research.
North America will remain the largest region over the forecast period due
to the growing focus on stem cells, biomedicine, and cancer research and rising
investment in the development of structure-based drug designs in the region.
Abcam, Merck, Thermo Fisher Scientific, Cell Signalling Technology, Santa Cruz Biotechnology, Perkinelmer, and Becton and Dickinson are the major suppliers in the research antibodies market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment